• Home
  • NHS
  • Sales
  • Focus-On
  • Research
  • Regulatory
  • Community Pharmacy
  • About PharmaSciMed
Menu

biosimilars

  • Home
  • biosimilars
The coming age of biosimilars
  • February 26, 2019
  • 0

Read more

Trending

  • Regulatory
CHMP endorses six new medicines
  • February 4, 2019
  • 0
NHS
  • NHS
NHS to add 1,000 social prescribers to ease GP load
  • January 30, 2019
  • 0
Janssen
  • Community Pharmacy
NHS mental health woes
  • January 24, 2019
  • 0
bristol Myers squibb, Celgene
  • Sales
BMS buys Celgene for $76bn
  • January 3, 2019
  • 0
rejected
  • NHS
NICE rejects Novartis’ migraine drug for routine use
  • January 9, 2019
  • 0
brexit
  • Focus-On
The reality of Brexit’s effect on pharma
  • January 9, 2019
  • 0

Recent Posts

  • Featured
  • Focus-On
Senate Finance Committee
The great American drug-pricing debacle
  • February 27, 2019
  • 0

Yesterday – Tuesday

The coming age of biosimilars
  • February 26, 2019
  • 0
Novartis acquires game-changing cardiovascular therapy
  • February 25, 2019
  • 0
spark therapeutics
Roche buys gene therapy company Spark for $4.3bn
  • February 25, 2019
  • 0
AbbVie
AbbVie and Voyager Therapeutics in Parkinson’s Pact
  • February 22, 2019
  • 0

Learn more

Copyright © 2021 Pharmascimed. All Rights Reserved.